Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease.
about
Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritisProtein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophagesPeriodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis.Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathwaysChronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKDAutoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.Homocitrullination Is a Novel Histone H1 Epigenetic Mark Dependent on Aryl Hydrocarbon Receptor Recruitment of Carbamoyl Phosphate Synthase 1.Myeloperoxidase evokes substantial vasomotor responses in isolated skeletal muscle arterioles of the rat.Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.Protein carbamylation is a hallmark of agingEndothelial function in a mouse model of myeloperoxidase deficiency.Autoantibodies to posttranslational modifications in rheumatoid arthritis.The role of monocytes in atherosclerotic coronary artery disease.Potential for chlorine gas-induced injury in the extrapulmonary vasculature.Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus.Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis.Emerging Role of Myeloperoxidase in the Prognosis of Nephrotic Syndrome Patients Before and After Steroid Therapy.Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis.Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates.Prediction of carbamylated lysine sites based on the one-class k-nearest neighbor method.Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population.The effect of triclosan on posttranslational modification of proteins through citrullination and carbamylation.Carbamylation of the amino-terminal residue (Gly1) of mouse serum amyloid A promotes amyloid formation in a cell culture model.[Protein molecular aging: which role in physiopathology?]Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function.Sources and Fates of Carbamyl Phosphate: A Labile Energy-Rich Molecule with Multiple Facets.
P2860
Q24629328-AE7D2130-6E60-448D-8381-539D102B7632Q30429333-5D123D56-DA8F-4162-8C37-48F4F0C8A330Q33904381-061CED28-5538-4064-9FEC-8413C5CEDA2AQ34026753-5767081F-2CE0-48F9-94F9-CF8DAA0D1308Q34249471-812BB640-EF34-4C30-9398-6231759A3925Q34981709-084D05A8-C723-49B2-AB0D-7FE27DDB2768Q35064221-47F098CA-A15D-471F-95C1-8E412B0E94F1Q35408694-6A418A59-7151-4C01-8FB3-DF0756B63A08Q35834431-DC0B24EA-3CB4-4360-9E86-CC6406518E60Q36282906-70830A30-837B-4F92-ABFC-5A833A6528ACQ36302434-A91801A6-4C02-4A1A-BAAA-0359657B1787Q36535109-207B9ED4-BB18-45B3-B5C9-36A32D622E8AQ36563327-F708B890-6E71-45E3-905D-EC8C4334A8F5Q37632236-A115B38E-AEE6-43BA-8BCE-D92F867714ADQ37693939-A073632A-BDDD-47A8-BC58-41EFFE42783BQ37766875-A982E178-D698-41A9-8982-35D0AB5D921AQ37770003-5B042969-93C9-4ACF-B5D2-8909F9A30800Q37986199-83D4448B-AA49-4530-807A-811B027AAE5AQ38395463-B8865B00-73E9-41F8-AC2D-A9E33E0BB88BQ39675520-F52FAD1A-3AC4-4659-91A9-236B4BFA9F5CQ40515685-8D04BEEA-6EB5-4AB2-9A36-AE3C75B3B821Q41146137-D6DC2C6C-229F-4064-B5E3-E50286656C28Q42472707-F3A3159F-3AB4-452D-8E5B-29DAB72DB155Q44845081-56259415-A157-4C6E-BA9F-F57C7E2D1316Q48033119-D8F8E489-94FE-481D-B223-F28B35AB2DE8Q48284447-6188B645-47D9-461B-8F3E-D7BE7426045AQ50955650-625D38E4-A6D5-4065-9B4B-9033084774F0Q51351788-F818D0C3-691F-47A4-BD97-4C46059AD8C3Q53520142-5D726C3D-0C6F-4827-9279-E847C8D70A70Q54222366-BEA34B57-FAAE-48F0-B9EE-E2D484E99D99Q55429528-13DD5A9E-DDCF-431D-8D70-D0599B4A6D6A
P2860
Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myeloperoxidase-mediated lipop ...... erosclerotic vascular disease.
@en
Myeloperoxidase-mediated lipop ...... erosclerotic vascular disease.
@nl
type
label
Myeloperoxidase-mediated lipop ...... erosclerotic vascular disease.
@en
Myeloperoxidase-mediated lipop ...... erosclerotic vascular disease.
@nl
prefLabel
Myeloperoxidase-mediated lipop ...... erosclerotic vascular disease.
@en
Myeloperoxidase-mediated lipop ...... erosclerotic vascular disease.
@nl
P356
P1433
P1476
Myeloperoxidase-mediated lipop ...... erosclerotic vascular disease.
@en
P2093
Sanjeev Sirpal
P304
P356
10.1042/CS20080322
P407
P577
2009-05-01T00:00:00Z